Synthesis and biological properties of a new series of anti-MRSA β-Lactams; 2-(thiazol-2-ylthio)carbapenems

Bioorganic and Medicinal Chemistry

Volumn 5, Issue 3, 1997, Pages 601-621

  Shinagawa, Hisatoshi ^a   Yamaga, Hiroshi ^a   Houchigai, Hitoshi ^a   Sumita, Yoshihiro ^a   Sunagawa, Makoto ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG STABILITY; DRUG SYNTHESIS; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; CARBAPENEMS; CEPHALOSPORINS; DIPEPTIDASES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MODELS, CHEMICAL; MODELS, MOLECULAR; PROTEIN BINDING; SERUM ALBUMIN; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031105521     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(96)00273-8     Document Type: Article

References (58)

1. 1. Jevons, M. P., Br. Med. J. 1961, 1, 124.
2. 2. Saravolatz, D. L.; Pohlod, D. J.; Arking, L. M., Ann. Intern. Med. 1982, 97, 325.
3. 3. Eykyn, S. J., Lancet. 1988, 8577, 100.
4. 4. Yokota, T.; Sekiguchi, R., Program Abstr. Intersci. Conf. Antimicrob. Agents Chemother. 22nd, abstr. no. 342, 1982.
5. 5. (a) Ubukata, K.; Yamashita, N.; Konno, M., Antimicrob. Agents Chemother. 1985, 27, 851;
6. (b) Utsui, Y.; Yokota, T., Antimicrob. Agents Chemother. 1985, 28, 397;
7. (c) Reynolds, P. E.; Fuller, C., FEMS Microbiol. Lett. 1986, 33, 251;
8. (d) Hartman, B. J.; Tomasz, A., J. Bacteriol. 1984, 158, 513.
9. 6. McCormick, M. H.; Stark, W. M.; Pittenger, G. E.; Pittenger, R. C.; Mcguire, G. M., Antibit. Ann. 1955-1956, 606.
10. 7. Kondo, S.; Iinuma, K.; Yamamoto, H.; Maeda, K.; Umezawa, H., J. Antibiot. 1973, 26, 412.
11. 8. Malanoski, G.; Collins, L.; Eliopoulos, C. T.; Moellering, Jr R. C.; Eliopoulos, G. M., Antimicrob. Agents Chemother., 1995, 39, 990.
12. 9. Tsushima, M.; Tamura, A.; Hara, T.; Iwamatsu, K.; Shibahara, S., Program and Abstracts of the 32nd Intersci. Conf. on Antimicrob. Agents Chemother., No. 394, 1992.
13. 10. Ternansky, R. J.; Draheim, S. E.; Pike, A. J.; Bell, F. W.; West, S. J.; Jordan, C. L.; Ernie Wu, C. Y.; Preston, D. A.; Alborn, W. Jr.; Kasher, J. S.; Hawkins, B. L., J. Med. Chem. 1993, 36, 1971.
14. 11. (a) Chang, G.; Fuida, W. C.; Still, W. C., J. Am. Chem. Soc. 1989, 111, 4379;
15. (b) Still, W. C.; Tempczyk, A.; Hawley, R. C.; Hendrickson, T., J. Am. Chem. Soc. 1990, 112, 6127.
16. 12. Sunagawa, M.; Yamaga, H.; Shinagawa, H.; Houchigai, H.; Sumita, Y., Bioorganic & Medicinal Chemistry Letters 1994, 4, 2793.
17. 13. Waddell, S. T.; Ratcliffe, R. W.; Szumiloski, S. P.; Wildonger, K. J.; Wilkening, R. R.; Blizzard, T. A.; Huber, J.; Kohler, J.; Dorso, K.; St Rose, E.; Sundelof, J. G.; Hammond, G. G., Bioorganic & Medicinal Chemistry Letters 1995, 5, 1427.
18. 14. (a) Wildonger, K. J.; Ratcliffe, R. W., J. Antibiotics 1993, 46, 1866;
19. (b) Sunagawa, M.; Matsumura, H.; Inoue, T.; Fukasawa, M.; Kato, M., J. Antibiotics 1991, 44, 459.
20. 15. (a) Scott, W.; Watt, G. W., J. Org. Chem. 1937, 2, 148;
21. (b) Yamamoto, Y., J. Pharm. Soc. Jpn. 1952, 72, 1124;
22. (c) Kanno, S.; Ohno, M., J. Pharm. Soc. Jpn. 1949, 69, 503;
23. (d) Buchman, E. R.; Reims, A. O.; Sargent, H., J. Org. Chem. 1941, 6, 764.
24. 16. (a) Nakagawa, S.; Kato, Y.; Fukatsu, H., Eur. Pat. Appl. 1991, 430037 A2 910605;
25. (b) Shih, D. H.; Cama, L.; Christensen, B. G., Tetrahedron Lett. 1985, 26, 587.
26. 17 . Emerson, W. S.; Patrick, Jr. T. M., J. Org. Chem. 1948, 13, 122.
27. 18. (a) Vernin, G.; Metzger, J., Bull. Soc. Chim. France. 1963, 2498;
28. (b) Muraoka, M.; Yamamoto, T.; Ebisawa, T.; Kobayashi, W., J. Chem. Soc. Perkin Trans. 1978, 1, 1017.
29. 19. Cohen, A. B.; Celeste, J. R.; Fan, R. N., Photogr. Sci. Eng. 1965, 9, 96.
30. 20. Hibino, T.; Suzuki, Y.; Okano, S.; Hara, Y.; Sato, E., Japan Koukai Tokkyo Kouhou JP 49041372 740418 Showa.
31. 21. Brown, D. J.; Cowden, W. B.; Grigg, G. W.; Kavulak, D., Aust. J. Chem. 1980, 33, 2291.
32. 22. Redemann, E. C.; Icke, R. N.; Alles, G. A., Org. Syn. III, 763.
33. 23. Chanon, M.; Metzger, J., Bull. Soc. Chim. France 1968, 2842.
34. 24. Mc Phee, W. C.; Klingsberg, E., Org. Syn. 1955, III, 119.
35. 25. (a) Kolosova, M. O., Zh. Priklad. Khim. 1963, 36, 931;
36. (b) Robba, M.; Moreau, R. C., Ann. Pharm. Franc. 1964, 22, 14.
37. 26. (a) Miolati, A., Gazz. Chim. Ital. 1893, 23, 575;
38. (b) Bastianelli, P.; Chanon, M.; Metzger, J., Bull. Soc. Chim. France, 1967, 6, 1948.
39. 27. Garreau, Y., Compt. Rend. Hebd. Seances Acad. Sci. 1947, 224, 841.
40. 28. Stewart, F.; Mathes, R., J. Org. Chem. 1949, 14, 1111.
41. 29. Kjellin, G.; Sandstrom, J., Acta Chem. Scand. 1969, 23, 2879.
42. 30. Deady, L. W.; Stanboroough, M. S., Aust. J. Chem. 1981, 34, 1295.
43. 31. El-Fehail Ali, F.; Gleason, J. G.; Hill, D. T.; Krell, R. D.; Kruse, C. H.; Lavanchy, P. G.; Volpe, B. W., J. Med. Chem. 1982, 25, 1235.
44. 32. Leanza, W. J.; Wildonger, K. J.; Miller, T. W.; Christensen, B. G., J. Med. Chem. 1979, 22, 1435.
45. 33. Hirom, P. C.; Millburn, P.; Smith, R. L., Xenobiotica 1976, 6, 55.
46. 34. Shargel, L.; Yu, A. B. C., Applied Biopharmaceutics and Pharmacokinetics, 3rd edn; Appleton & Lange: Norwalk, 1993, pp 77-110.
47. 35. Gregory, I. G., Recent Advances in the Chemistry of β-Lactam Antibiotics; Royal Society of Chemistry: London, 1980.
48. 36. (a) Schmitt, S. M.; Salzmann, T. N.; Shin, D. H.; Cristensen, B. G., J. Antibiotics 1988, 41, 780;
49. (b) Nagao, Y.; Nagase, Y.; Kumagai, T.; Matsunaga, H.; Abe, T.; Shimada, O.; Hayashi, T.; Inoue, Y., J. Org. Chem. 1992, 57, 4243;
50. (c) Imuta, M.; Itani, H.; Ona, H.; Konoike, T.; Uyeo, S.; Kimura, Y.; Miwa, H.; Matsuura, S.; Yoshida, T., Chem. Pharm. Bull. 1991, 39, 672;
51. (d) Sunagawa, M.; Matsumura, H.; Inoue, T.; Yamaga, H.; Fukasawa, M., J. Antibiotics 1992, 45, 971.
52. 37. (a) Kim, C. U.; Luh, B. Y.; Misco, P. F.; Hitchcock, M. J. M., J. Med. Chem. 1989, 32, 601;
53. (b) Kim, C. U.; Misco, P. F.; Luh, B. Y.; Hitchcock, M. J. M., J. Antibiotics 1987, 40, 1707.
54. 40, the distance between the cation (the nitrogen atom) and the carbapenem skeleton (the oxygen atom of the carboxylic acid) was within about 8 Å.
55. 39. Sumita, Y.; Nouda, H.; Kanazawa, K.; Fukasawa, M., Antimicrob. Agents Chemother. 1995, 39, 910.
56. 40. Berger-Bächi, B.; Strässle, A.; Kayser, F. H., Eur. J. Clin. Misrobiol. 1986, 5, 697.
57. 41. Fukasawa, M.; Sumita, Y.; Harabe, E. T.; Tanio, T.; Nouda, H.; Kohzuki, T.; Okuda, T.; Matsumura, H.; Sunagawa, M., Antimicrob. Agents Chemother. 1992, 36, 1577.
58. 42. Sumita, Y.; Fukasawa, M.; Mitsuhashi, S.; Inoue, M., J. Antimicrob. Chemother. 1995, 35, 473.